Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.

Balance Sheet for PharmaCyte Biotech Inc (PMCB)

$ 0.0495   -0.0015 (-2.94%) Volume: 951.54k 3:48 PM EST Nov 16, 2018
Statement: View:
Assets [+] in Thousands of Dollars
04/2018 04/2017 04/2016 04/2015 04/2014
Cash and Equivalents 1,060 3,464 1,921 2,700 3,616
Restrictable Cash - - - - -
Marketable Securities - - - - -
Accounts Receivable - - - - -
Loans Receivable - - - - -
Other Receivables - - - - -
Receivables - - - - -
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other - - - - -
Inventories, Adjustments & Allowances - - - - -
Inventories - - - - -
Prepaid Expenses 224 74 110 1,468 570
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 1,284 3,539 2,031 4,168 4,187
Land and Improvements - - - - -
Buildings and Improvement - - - - -
Machinery, Furniture and Equipment - - - - -
Construction in Progress - - - - -
Fixed Assets, Other - - - - -
Fixed Assets, Total - - - - -
Gross Fixed Assets - - - - -
Accumulated Depreciation - - - - -
Net Fixed Assets - - - - -
Intangibles 3,549 3,549 3,549 3,549 3,549
Cost in Excess - - - - -
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets 7 7 8 8 8
Total Non-Current Assets 5,129 5,129 5,129 5,129 5,129
Total Assets 6,413 8,667 7,160 9,297 9,316
Liabilities [+] in Thousands of Dollars
04/2018 04/2017 04/2016 04/2015 04/2014
Accounts Payable 353 366 336 497 332
Short Term Debt - - - - 860
Notes Payable - - - - -
Accrued Expenses 292 214 76 3 42
Accrued Liabilities 292 214 76 3 42
Deferred Revenues - - - - -
Current Deferred Income Taxes - - - - -
Other Current Liabilities - 0 225 1,021 (860)
Total Current Liabilities 644 580 638 1,520 374
Long Term Debt - - - - -
Deferred Income Tax - - - - -
Other Non-Current Liabilities - - - - (500)
Minority Interest - - - - -
Capital Lease Obligations - - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities - - - - (500)
Total Liabilities 644 580 638 1,520 (126)
Preferred Shareholder's Equity - - - - 500
Common Shareholder's Equity 5,769 8,087 6,523 7,777 8,942
Common Par 101 91 78 73 69
Additional Paid in Capital 101,636 97,130 91,135 86,330 75,999
Cumulative Translation Adjustments - - - - -
Retained Earnings (95,964) (89,135) (84,692) (78,628) (68,700)
Treasury Stock - - - - -
Other Equity Adjustments (5) 2 1 1 -
Total Capitalization 5,769 8,087 6,523 7,777 9,442
Total Equity 5,769 8,087 6,523 7,777 9,442
Total Liabilities & Shareholder's Equity 6,413 8,667 7,160 9,297 9,316
Cash Flow (6,829) (4,444) (6,064) (10,855) (27,254)
Working Capital 640 2,958 1,393 2,648 3,813
Free Cash Flow (5,079) (3,339) (4,346) (5,060) (5,055)
Invested Capital 5,769 8,087 6,523 7,777 8,942
Shares Outstanding - Common Class Only 1,013,261 905,349 781,233 732,760 690,616
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 1,013,261 905,349 781,233 732,760 690,616
Total Common Shares Outstanding 1,013,261 905,349 781,233 732,760 690,616
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 968,642 845,308 752,403 704,328 583,220
Diluted Weighted Shares Outstanding 968,642 845,308 752,403 704,328 583,220